Filed: 10/5/2022ACC: 0000950123-22-010047
📋 What this filing means
VIDA VENTURES ADVISORS, LLC filed this quarterly 13F‑HR report disclosing 8 equity positions with a total reported market value of $111.4K. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
8
Positions
$111.4K
Total AUM (reported)
18.84M
Total Shares
Allocation by class
COMMON STOCK$91.1K81.7%
ORDINARY SHARES$20.4K18.3%
Portfolio Concentration
Top 3$74.0K66.4%
4–10$37.4K33.6%
Top 3 weight
66.4%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 18.84M
Sole
Full voting authority
18.84M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole8
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings8
Rows:
Dyne Therapeutics, Inc.
SOLEShares2.22M
TypeSH
Market value$28.2K
25.30%
Sole
2.22M
Shared
0.00
None
0.00
Kinnate Biopharma, Inc.
SOLEShares2.21M
TypeSH
Market value$26.4K
23.68%
Sole
2.21M
Shared
0.00
None
0.00
Allogene Therapeutics, Inc.
SOLEShares1.80M
TypeSH
Market value$19.4K
17.43%
Sole
1.80M
Shared
0.00
None
0.00
Centessa Pharmaceuticals plc
SOLEShares3.93M
TypeSH
Market value$15.8K
14.18%
Sole
3.93M
Shared
0.00
None
0.00
Kronos Bio, Inc.
SOLEShares2.77M
TypeSH
Market value$9.3K
8.31%
Sole
2.77M
Shared
0.00
None
0.00
Praxis Precision Medicines, Inc.
SOLEShares2.94M
TypeSH
Market value$6.7K
5.99%
Sole
2.94M
Shared
0.00
None
0.00
LianBio
SOLEShares2.28M
TypeSH
Market value$4.6K
4.10%
Sole
2.28M
Shared
0.00
None
0.00
Homology Medicines, Inc.
SOLEShares696.29K
TypeSH
Market value$1.1K
1.01%
Sole
696.29K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Dyne Therapeutics, Inc.SOLE | Common Stock | 2.22M | SH | $28.2K 25.30% | 2.22M | 0.00 | 0.00 |
Kinnate Biopharma, Inc.SOLE | Common Stock | 2.21M | SH | $26.4K 23.68% | 2.21M | 0.00 | 0.00 |
Allogene Therapeutics, Inc.SOLE | Common Stock | 1.80M | SH | $19.4K 17.43% | 1.80M | 0.00 | 0.00 |
Centessa Pharmaceuticals plcSOLE | Ordinary Shares | 3.93M | SH | $15.8K 14.18% | 3.93M | 0.00 | 0.00 |
Kronos Bio, Inc.SOLE | Common Stock | 2.77M | SH | $9.3K 8.31% | 2.77M | 0.00 | 0.00 |
Praxis Precision Medicines, Inc.SOLE | Common Stock | 2.94M | SH | $6.7K 5.99% | 2.94M | 0.00 | 0.00 |
LianBioSOLE | Ordinary Shares | 2.28M | SH | $4.6K 4.10% | 2.28M | 0.00 | 0.00 |
Homology Medicines, Inc.SOLE | Common Stock | 696.29K | SH | $1.1K 1.01% | 696.29K | 0.00 | 0.00 |